-
The first COVID-19 vaccines to hit the market will not be approved for use in children. Researchers must figure out if the vaccines are safe and effective in kids.
-
Operation Warp Speed is allocating the first batch of 6.4 million COVID vaccines to states, based on population. This circumvents a CDC advisory committee, which proposed allocation based on risk.
-
A newly approved drug can extend the lives of children with progeria, a rare disorder that causes rapid aging. The drug is the result of one family's effort to help a child with the fatal condition.
-
The pharmaceutical giant and partner BioNTech announced Friday that they are submitting a formal request to the Food and Drug Administration, just days after the vaccine was shown to be 95% effective.
-
The CDC's planning guidance for states includes multiple scenarios for the rollout of a vaccine this year, including possibly having a limited number of doses available in October and November.
-
Doctors have a new option for suicidal patients. It's a fast-acting nasal spray containing a version of the anesthetic ketamine.
-
Animal and human trials are promising, Dr. Anthony Fauci tells lawmakers Friday, and the government is preparing for widespread distribution once a vaccine is shown to be safe and effective.
-
House Democrats press the leaders of federal agencies for details on whether President Trump has stymied health experts from taking more effective action to stem the spread of the coronavirus.
-
To speed vaccine production from years to months, companies must start making a vaccine in large quantities even before it's clear a vaccine works.
-
Gilead Sciences is donating its initial supply of the experimental treatment for COVID-19. The federal government is deciding where the scarce medicine goes, and there are questions about the choices.